Broncus Holding Past Earnings Performance
Past criteria checks 0/6
Broncus Holding has been growing earnings at an average annual rate of 21.7%, while the Medical Equipment industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 5.6% per year.
Key information
21.7%
Earnings growth rate
34.3%
EPS growth rate
| Medical Equipment Industry Growth | 13.7% |
| Revenue growth rate | 5.6% |
| Return on equity | -12.0% |
| Net Margin | -244.2% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
We Think Broncus Holding (HKG:2216) Needs To Drive Business Growth Carefully
Mar 21
Broncus Holding (HKG:2216) Is In A Good Position To Deliver On Growth Plans
Nov 30Will Broncus Holding (HKG:2216) Spend Its Cash Wisely?
May 31Companies Like Broncus Holding (HKG:2216) Are In A Position To Invest In Growth
Feb 27An Intrinsic Calculation For Broncus Holding Corporation (HKG:2216) Suggests It's 47% Undervalued
Dec 06Analysts Just Slashed Their Broncus Holding Corporation (HKG:2216) EPS Numbers
Sep 04Here's Why We're Not Too Worried About Broncus Holding's (HKG:2216) Cash Burn Situation
Jun 21Revenue & Expenses Breakdown
How Broncus Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 9 | -21 | 17 | 16 |
| 31 Mar 24 | 9 | -25 | 18 | 18 |
| 31 Dec 23 | 10 | -28 | 20 | 20 |
| 30 Sep 23 | 11 | -27 | 21 | 20 |
| 30 Jun 23 | 11 | -27 | 22 | 20 |
| 31 Mar 23 | 10 | -27 | 21 | 20 |
| 31 Dec 22 | 9 | -28 | 21 | 19 |
| 30 Sep 22 | 10 | -119 | 24 | 19 |
| 30 Jun 22 | 11 | -209 | 26 | 18 |
| 31 Mar 22 | 11 | -222 | 29 | 17 |
| 31 Dec 21 | 11 | -236 | 32 | 17 |
| 30 Sep 21 | 8 | -156 | 28 | 15 |
| 30 Jun 21 | 5 | -76 | 24 | 13 |
| 31 Mar 21 | 4 | -62 | 19 | 11 |
| 31 Dec 20 | 3 | -48 | 14 | 9 |
| 31 Dec 19 | 8 | -32 | 17 | 11 |
Quality Earnings: 2216 is currently unprofitable.
Growing Profit Margin: 2216 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2216 is unprofitable, but has reduced losses over the past 5 years at a rate of 21.7% per year.
Accelerating Growth: Unable to compare 2216's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2216 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-4.3%).
Return on Equity
High ROE: 2216 has a negative Return on Equity (-12.02%), as it is currently unprofitable.